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THE UNIVERSITY OF TENNESSEE 
COLLEGE OF VETERINARY MEDICINE 
Office of the Dean 
P. O. Box 1071 
Knoxville, TN 37901-1071July 15, 1994 (615) 974-7262 
The Center of Excellence in Livestock Diseases and Human Health has 
completed another productive year. This success can be traced to the Center's 
continuing efforts to focus on selected areas of emphasis, support the most 
productive projects, and invest in only the most promising young investigators 
and new projects. Again this year recommendations by both the external and 
internal advisory committees have provided the scientific basis for both policy 
and technical decisions made by the Center. 
While the Center supported projects in the areas of Inflammation and Host 
Defense, as well as Infectious Diseases and PopUlation Medicine, this past year 
particular emphasis was placed on Growth Factors and In Vitro Toxicology. 
With this emphasis two new faculty members will be part of the Center as of 
July 1994. Dr. Joyce Merryman will join the Growth Factor group. Dr. Daniel 
Ward will join the In Vitro Toxicology and Toxicokenetics group. Therefore, 
capital equipment purchases were targeted toward these groups. 
A multiuser in vitro toxicology laboratory was the result of College Renovations. 
Equipment for this facility was purchased with Center funds. A large 
sterilization unit was also purchased. Although the sterilizer may be used by 
all members of the College, it will directly benefit the Growth Factor Group. 
Continued support of the Center will assist us in research focused on livestock 
disease and human health which is important to the region, the State of 
Tennessee and the nation as a whole. This coming year we will continue to do 
the things we do with excellence as evident by the projects headed by Drs. 
Bochsler, Brian, McDonald, Potgieter, Rouse, Schuller, and Wilkinson. 
We will continue to place a premium on projects using modern molecular 
biological techniques because they hold the greatest promise for extramural 
funding. We also plan to strengthen our research in the area of applied 
molecular genetics and our interaction with Oak Ridge National Laboratory. 
Therefore, we have renamed the Growth Factor Group the Growth Factor and 
Molecular Genetics Group. 
We end this year and look forward to the next with a successful Center, in large 
part due to a diligent and competent core of faculty and staff dedicated to 
excellence in research in livestock disease and human health. 
,/------._! 
\ G.M.H. Shires 
Dean-and Director of the Center 
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I. PROGRAMMATIC REPORT 
LA. RENAMING OF A RESEARCH GROUP 
One of the five major research groups, Growth Factors, has been renamed Growth 
Factors and Molecular Genetics. This name change reflects the Group's and Center's 
emphasis on molecular genetics and the expanded interaction with the Molecular 
Genetics group of the Biology Division of Oak Ridge National Laboratory. This 
interaction is coordinated by DRS. E. WILKINSON and D. SLAUSON. The area of 
molecular genetics focuses on the characterization of the role of specific genes in 
important diseases in mutants, especially mice. Involved in this is the phenotypic, 
cellular, and molecular analysis of spontaneous mutants, insertional mutants, saturation 
mutants, knockouts, and traditional transgenic animals. Studies such as these use all the 
tools of modern molecular biology, as well as the traditional tools of immunology, 
pathology, and developmental biology to completely evaluate the role of specific genes in 
specific diseases. 
I.B. PERSONNEL CHANGES 
I.B.I. Personnel Additions 
DR. DANIEL A. WARD joins the "In Vitro Toxicology and Toxicokinetics" 
(lVTT) group. He received his D.V.M. from The University of Tennessee and his 
Ph.D. from the University of Georgia. 
DR. JOYCE I. MERRYMAN joins the "Growth Factors and Molecular 
Genetics" (GFMG) group. She received both her D.V.M. and Ph.D. from The 
Ohio State University. 
I.B.2. 	 Personnel Deletions 

None 

I.e. CENTER GOALS AND MAJOR PROGRAMMATIC ACTIVITY 
GOAL I: 	To IMPROVE THE QUALITY OF HUMAN LIFE THROUGH BETTER ANIMAL 
HEALTH. 
Research performed by DR. J. GODKIN in conjunction with DR. L. MUNSON has 
focused on fetal-maternal interactions that contribute to the maintenance of pregnancy 
and growth and development of the embryo in domestic farm animals. This work has led 
to a new Department of Agriculture grant which began this year.. This past year, studies 
were completed on the fetal-maternal interactions between the embryonic protein 
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interferon tau ('t) believed to be the embryonic signal that mediates the maintenance of 
early pregnancy in ruminants. Two uterine cell culture systems were established, and it 
was demonstrated that recombinant bovine IFN't inhibited, and oxytocin stimulated, 
uterine epithelial cell production of prostaglandins (PG) F2u and E2 but had no 
measurable effects on stromal cells. In addition, IFN't had no effect on uterine cell 
protein production or PG synthase mRNA production. Results demonstrate that IFN't 
maintains early pregnancy by inhibiting uterine epithelial cell production of PGF2u. 
This action maintains pregnancy through maintenance of progesterone production by the 
corpus luteum which is susceptible to regression mediated by PGF2u. 
Expression oftransforming growth factor-beta (TGF-~), a potent regulator ofcell 
growth, was identified and characterized in ovine and bovine uterine endometrium and 
embryos. TGF-~ 1 and ~2 was identified in tissues by immunocytochemical procedures 
and TGF-~l, ~2 and ~3 mRNA's were quantitated by scanning densitometry of slot blots. 
Each TGF-~ isoform exhibited different temporal and tissue specific expression 
suggesting unique functions. IFN't was shown to diminish uterine TGF -~ expression. 
Retinol-binding protein (RBP) , the vitamin A transport protein, was discovered to 
be a product of ovine and bovine blastocysts, placental membranes and uterine 
endometrium. Expression of RBP and its mRNA was identified in tissues by 
immunocytochemistry and in sill! hybridization procedures. Changes in the level of 
mRNA expression in uterine and conceptus tissues were quantitated by scanning 
densitometry of slot blots. Expression of conceptus RBP was shown to be 
developmentally regulated, while uterine RBP expression was modulated by ovarian 
steroids and the conceptus protein, IFN't. 
GOAL 2: 	To AUGMENT LIVESTOCK DISEASE RESEARCH CAPABILITIES IN THE 
INSTITUTE OF AGRICULTURE. 
DR. P. BOCHSLER and DR. D. SLAUSON continue their studies of the response of 
cattle to the presence of gram-negative bacterial pathogens, particularly one of the toxins 
released by these bacteria. Bacteria of this type are known to be responsible for several 
types of clinical disease of cattle, including forms of pneumonia, mastitis, and diarrhetic 
disease. The toxin they study is referred to as endotoxin or LPS, and it incites fever, 
depression, and other clinical symptoms in cattle, and may cause or contribute to causes 
of death. They have made significant progress in identification of some of the pathways 
and mediators that are important in the response of cattle to endotoxin. A few of the 
results of these studies include identification ofa bovine serum LPS-binding protein that 
is important in the response to endotoxin/LPS, and study of mediators of inflammatory 
disease in cattle, such as TNF u and tissue factor. 
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GOAL 3: To IDENTIFY AND CHARACTERIZE ANIMAL DISEASES THAT ARE 
ANALOGOUS TO HUMAN DISEASES. 
DR. S. MENDIS-HANDAGAMA has continued her basic research on the role of 
peroxisomes in the steroidogenic process that was investigated using primarily Leydig 
cells in vivo in adult rats. Previously, her research has shown that sterol carrier protein-2 
(SCP2), which binds to cholesterol in 1: 1: molar ratio is highly concentrated in Leydig 
cell peroxisomes. Continuation of this line of research has recently revealed yet 
undiscovered aspects in the pathway of steroidogenesis in general, and particularly in 
Leydig cells. The results showed that with acute luteinizing hormone (LH) stimulation: 
(a) SCP2 gets highly concentrated in Leydig cell peroxisomes (5-fold above control 
values); (b) this is due to redistribution and not due to ~ novo synthesis of SCP2', (c) 
peroxisomes rich in SCP2 fuse with Leydig cell mitochondria and, (d) this fusion of 
peroxisomes and mitochondria is associated with transfer of SCP2 into mitochondria. 
Whether SCP2 delivers cholesterol at the inner mitochondrial membrane, or 
whether SPC2 could travel into the mitochondria with cholesterol was an unresolved 
issue in the process of steroidogenesis. Though tissue differences are possible, her 
studies showed for the first time that in steroidogenic cells in the testis, SCP 2 moves into 
mitochondria with LH stimulation, suggesting that SCP2 delivers cholesterol into the 
inner mitochondrial membrane for side chain cleavage reaction to product pregnenolone. 
Moreover, these studies revealed for the first time that peroxisomes are responsible for 
this mechanism of cholesterol transport during steroid hormone biosynthesis in Leydig 
cells. This work has lead to Dr. S. Mendis-Handagama receiving this year a National 
Science Foundation grant to continue her work on understanding the mechanisms 
involved in movement ofperoxisomes towards mitochondria for cholesterol delivery. 
During the past year DR. R. SHULL continued work on his long-term program 
aimed at discovering effective novel therapy for canine MPS I, a model of the same 
disease in children. A total of 6 gene transfer/gene therapy experiments were conducted 
utilizing 4 MPS I-affected dogs and 3 unaffected animals. The initial goal was to 
document survival of hematopoietic stem cells in long-term bone marrow culture after 
infection with a retroviral vector carrying the gene for the enzyme missing MPS I. In 
later experiments, transfected cells were returned to 2 affected dogs and evidence of in 
vivo gene expression sought. Initial results were not encouraging, as has been the 
experience at other institutions where similar work on gene therapy in large animal 
species is being conducted. In collaboration with individuals at the University of 
Toronto, Canada, a third dog was treated with cells modified genetically in a long-term 
culture system. Results of these studies are still being collected at this time, but evidence 
of at least intermittent enzyme production has been found . Six MPS I -affected dogs were 
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also treated by intravenous infusion of recombinant human enzyme. These trials were 
successful in documenting that human enzyme could be taken up by canine cells and that 
it could have dramatic effects in some tissues on the abnormal storage products that are 
typical of the untreated disease. 
DR. T. SCHULTZ has completed studies aimed at predicting the toxicity of 
oxygen-containing aliphatic and aromatic industrial chemicals. This work was designed 
to develop mathematical models that predict the toxicity of chemicals from their 
molecular structure and, thus, eliminating the need to test them on animals. This past 
year, work centered on examining the toxicity of esters including benzoates and 
phthalates. The investigations have shown that in animals with high esterase activity, 
esters are more toxic than in animals with low esterase active. Moreover, when toxicity 
was corrected for this activity and a volume fraction analyses performed, a technique 
developed by Dr. Schultz's group, toxicity can be attributed to the nonpolar narcosis 
mechanism ofaction. This information goes a long way in explaining the highly variable 
toxicity data for esters reported in the literature. 
GOAL 4: To STUDY ANIMAL MODELS FOR BETTER UNDERSTANDING OF HUMAN DISEASE. 
DR. H. SCHULLER'S research programs in the area of lung tumors has continued 
to do very well. Among the findings of Dr. Schuller's laboratory is that women who 
smoke during pregnancy genetically predispose their children to lung tumors as the 
children become adults. Since not all lung tumors are the result of smoking, research is 
expanding to determine how other pollutants impact the development of lung cancer. 
Moreover, Dr. Schuller's research has been to develop a neuroendocrine lung 
carcinogenesis model in hamsters. She has determined the etiology of the model. 
Moreover, in collaboration with Byk Guldden Pharmaceuticals, she and DR. K. HAHN 
evaluated a novel calcium channel blocker, Dexniguldipine, which inhibits tumor cell 
growth. This agent is currently in animal and human clinical trials. 
The main objective during the past year for DR. B. ROUSE was to understand the 
role of various cytokines in the immunopathogenesis of herpetic stromal keratitis (HSK). 
Previous studies from the laboratory have shown the predominant role of Th 1 derived 
cytokines. This was done by isolating cells from the eye and stimulating them in vitro in 
various ways. While this could be a true representation of events in vivo, there is still a 
possibility that in Yi1m manipUlations influencing the cytokine profile. Hence, in order to 
obtain a better picture of in vivo events, they examined the cytokine mRNA profile in 
total cellular RNA from cells isolated from the cornea. For this, they developed a highly 
sensitive and specific quantitative competitive reverse transcription polymerase chain 
reaction (RT-Q-PCR). The development of this approach was essential since the 
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cytokine mRNA in vivo is in low abundance and the number of cells that can be obtained 
from the mouse cornea is very limited. The detailed methodology has been published in 
an immunologicaljoumal. Essentially, the quantitation relies on the competition of target 
DNA and internal control DNA for all the reactants including the primer sets. 
The cytokine gene expression study was extended to an extremely valuable but 
expensive model, namely the SCID mouse, which was reconstituted to generate HSK 
with T cells from immune or naive mice (2). Overall, the SCID mouse data was 
consistent with immunocompetent mice. In general, the in vivo cytokine gene expression 
analyses during HSK demonstrated a clear role for Th-I derived cytokines and it appears 
that IFN -'t is the potent inflammatory mediator in the cornea. 
Using this approach, they examined the inflammatory and T cell derived cytokine 
mRNA levels in both immunocompetent and reconstituted SCID mouse during the course 
of HSK development. Their data show that with regard to inflammatory cytokines, in 
both draining lymph nodes (DLN) and cornea, IL-I , IL-6, TNFa mRNA were expressed 
in relation to the clinical severity during the onset and clinical phases of HSK. There was 
a dramatic influx of TNFa in the more severe clinical lesions. The concentration of 
inflammatory cytokines were more in the ocular tissue over the DLN. With regard to the 
T cell derived cytokines, there were two surges in both DLN and ocular cells. One 
confined to early phase at 7-day post infection and other to the clinical phase. In the 
DLN, both Thl and Th2 were seen, but Thl predominated. In the ocular tissues, a 
transient ThO type (11-2, IFN't, IL-4) was evident in the early phase. Later phase in the 
ocular tissue was confined to the Th 1 pattern. 
Presently, Dr. Rouse and his co-workers are working on in situ hybridization 
method in order to further characterize the cytokine profile (gene expression) and viral 
gene expression during the course of HSK. This is to identify and localize the cells 
involved in the immunopathology of HSK. Towards this end, they have developed 
specific probes for detection of viral genes, inflammatory cytokine genes and T cell 
derived cytokine genes. They have standardized the methodology for the detection of gB 
(viral gene), IL-2, IFN-'t, IL-6 mRNA in cells prepared by cytospin. Studies are in 
progress in order to apply this procedure to sections of cornea obtained during various 
stages of the development of HSK. 
DR. M. MILLER in conjunction with DR. H. SCHULLER has been examining the 
role of oncogens in transplacental carcinogenesis. One goal of this research project was 
to adapt the polymerase chain reaction technique to amplify small quantities of DNA 
from paraffin-embedded tissues. This has been successfully done, and amplified 
sequences of the hamster Ki-ras gene obtained. In dose response experiments, a readily 
detectable signal was obtained by Southern blot analysis of the amplified DNA in less 
than 24 hours of autoradiographic exposure from as little as the equivalent of a 1 micron 
piece of tissue from embedded hamster lung samples. This technique was pivotal to Dr. 
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M. Miller' s success this year in obtaining a National Institutes of Health grant to examine 
the role of oncogens in transplacental carcinogenesis in the mouse model. During this 
past year, Dr. M. Miller has trained Dr. Schaeffer and her technical staff on the proper 
way to perfonn the high i.p. injections on pregnant mice. They have established a 
breeding colony and set up an excellent record keeping system to track the mice through 
the one-year study. They have initiated the carcinogenicity bioassay and have filled the 
first treatment group. As noted earlier, his previous research on gene mutations were 
conducted in hamsters. Thus, he has also used COE support to purchase amplimers to the 
mouse Ki-ras gene and have amplified DNA by the standard procedures described in the 
literature and obtained very good results. His group are also standardizing our research 
protocols to extract DNA from paraffin embedded mouse tissues. Thus, when the mouse 
bioassay is completed and the mice are euthanized, they will be ready to begin the 
molecular biology analysis immediately. Use of the COE funds has thus allowed him to 
optimize the reaction conditions early in the study, which will save him a great deal of 
time later. 
During the past year, DR. E. WILKINSON has continued to make great strides in 
characterizing the cells from Tg737 mice that are responsible for development of the 
kidney and liver lesion in this transgenic mouse model of autosomal recessive polycystic 
kidney disease. This work is in conjunction with investigators at the Biology Division of 
Oak Ridge National Laboratory. In general, studies continue to further define normal 
structure and function of the Tg737 gene, determine how mutations in the gene result in 
the pathological changes seen in the disease and to identify other genes associated with 
expression of the disease . Specific examples have been included. Dr. Wilkinson's 
laboratory has begun an analysis of the ability of transformed cells from previously 
isolated cell lines to produce both hepatocellular carcinomas and cholangiocarcinomas 
in mice. These studies involved both the transplantation of transformed oval cells into 
nude mice and the treatment of mutant mice with hepatic carcinogens. They have 
generated transgenic mice that express the Tg737 gene from a different promoter and 
used these mice to correct the defect in the kidney but not in the liver of offspring of 
mutant mice bred to transgenic mice. Moreover, they are now using these "phenotype 
rescued" mice to evaluate the log tenn effects of the liver lesion on the health of the 
animals and to utilize these animals for studies of the role of oval cells in liver cancer. In 
addition, collaborative efforts have also generated data to suggest that the Tg737 gene 
may be involved in liver cancer. Mutations in the Tg737 gene have been found in a high 
percentage of chemically induced liver tumors in rodents. Further work by. Dr. 
Wilkinson's group this past year completed the analysis of the FVB TgN737Rpw mice. 
This work described the detailed pathology ofthe kidney and liver lesions. 
In another collaborative project, DR. B. ROUSE ' S laboratory with DR. E. 
WILKINSON ' S laboratory have recently completed an analysis of the cellular basis for the 
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severe lymphoproliferative disease in scurfy mIce. These investigations utilized a 
number of "knockout" mice that lacked important molecules involved in the normal 
immune response The X-linked recessive mutation scurfy (sf) results in a phenotype 
characterized by a rapidly fatal immune disorder involving the skin and lymphoid 
systems. In order to understand better the immunobiology of the scurfy mouse, they have 
undertaken a series of experiments that investigate the role of the thymus and its 
components in the etiology and expression of scurfy disease. A few of the several 
important observations are noted. Results from experiments involving the transplantation 
of scurfy fetal thymi into H-2-compatible nude and SCID mice indicated that scurfy 
disease acts upon the fetal thymic environment as early as day-14 in development. Other 
experiments involving the selective transfer of wild-type or scurfy thymic components 
demonstrated that both sf-derived T cell precursors, and a genetically sf thymic 
microenvironment were necessary for disease expression. In addition, the roles of CD4 
or CD8 single-positive T cells were evaluated. This was accomplished by treating scurfy 
neonates with monoclonal antibodies directed against the CD4 or CD8 molecules and by 
breeding the scurfy mutation onto mice that lacked either CD4+ or CD8+ T cells. Results 
implicated CD4+ DC8- T cells as the critical effector cells in the pathogenesis ofscurfy 
disease . 
GOAL 5: 	 To UNDERSTAND THE PATHOGENESIS AND CHARACTERIZE THE 
CAUSATIVE AGENTS OF COMMON DISEASES IMPORTANT TO TENNESSEE. 
Fescue toxicosis remains one of the most costly disease syndromes to Tennessee 
beef producers. Studies in DR. J. OLIVER'S laboratory during the past year have 
continued to focus on the mechanism(s) of toxic tall fescue alkaloids in cattle, using 
alkaloid effects on blood vessels to project cause-and-effect relationships to the animal as 
a whole. 
During the past year, the mastitis research team in DR. S. OLIVER' S laboratory 
has developed a technique using Instagene purification matrix for DNA isolation. This 
technique is rapid, economical, and yields sufficiently pure DNA template for polymerase 
chain reaction from both gram-negative and gram-positive bacteria for randomly 
amplified polymorphic DNA (RAPD) fingerprinting. They also have evaluated 20 
potential oligonucleotide primers for RAPD fingerprinting of 19 different reference 
strains belonging to the family Enterobacteriaceae, and the genera Enterococcus, 
Staphylococcus~ and Streptococcus. Criteria for selection of potential primers were based 
on fingerprint patterns analyzed for number and size of RAPD fragments and absorbance 
of fragments using gel analysis software. A proposed bacterial species identification 
scheme was developed. This scheme will be helpful in identifying particular species 
associated with a given mastitis case. 
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Coronaviruses cause some of the most costly respiratory and gastroenteric 
diseases in domestic livestock and fowl. Yet vaccines to control their spread are often not 
effective because of the special challenges of inducing immunity at mucosal surfaces and 
because coronaviruses mutate rapidly. DR. D. BRIAN's laboratory investigates 
coronaviruses that infect many animal species, including cows. By studying the 
molecular biology of bovine coronavirus replication, Dr. Brian's laboratory has identified 
potential sites in the viral genome for targeted antiviral therapy and uncovered two 
potential mechanisms ofpersistent infection. Most excitingly, they have discovered a 
subviral replicon that they have cloned and engineered to carry viral immunogens and 
other potential antiviral or therapeutic molecules. 
GOAL 6: To IMPROVE THE CAPABILITIES OF THE COLLEGE OF VETERINARY 
MEDICINE, THE COLLEGE OF AGRICULTURE, AND THE AGRICULTURAL 
EXPERIMENT STATION TO DEAL WITH THESE DISEASES. 
Work continues on the molecular biology and immune response to bovine viral 
diarrhea virus. DR. L. POTGIETER's laboratory has as their goal with BVDV research, 
the development of improved diagnostics and immunoprophylaxis. Investigation focuses 
on the structural proteins of this virus. These proteins are responsible for induction of the 
protective immune response. The three major structural protein-encoding genes have 
been cloned, analyzed, and expressed. Using these expression products, their goal is to 
develop a sensitive and specific serological test that is very economical. Further, these 
proteins may be subcloned into live virus vectors for use in recombinant live vaccines. 
Antibodies induced by these proteins in animals were found to have neutralizing 
capabilities. This pathogen is associated with respiratory and reproductive disease 
leading to considerable financial loss. Improvement in these two areas ofBVDV control, 
diagnosis and immunoprophylaxis, will have significant impact on the cattle industry. 
Additionally, work is ongoing to evaluate the ovine respiratory syncytial virus at 
the molecular level. The surface protein responsible for viral attachment and induction of 
protective immunity to this virus, the G glycoprotein, has been cloned and sequenced, 
and the nucleotide sequence has been extensively analyzed. The gene encoding the 
non structural proteins 1 a, 1b, and 1 C of ORSV has also been cloned, sequenced, and 
analyzed. This is the only ruminant RSV IA-C genes to be sequenced to date. Cloning 
and sequencing of the G glycoprotein of ovine RSV adds to the information they have 
from the bovine RSV. This knowledge will be useful for the development of sensitive 
and specific diagnostic assays, as well as for the development of an effective vaccine. 
Further, the analogy to the human RSV may prove to be very useful for development ofa 
suitable animal model for this significant human pathogen. This work is of interest to 
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NIH, and we anticipate significant extramural funding next year. The sequencing of the 
1 C gene will also be important for guiding vaccine and diagnostic assay development. 
GOAL 7: 	 To IMPROVE FACILITIES TO ENABLE THE COLLEGE OF VETERINARY 
MEDICINE TO STUDY MORE EFFECTIVE INFECTIOUS AND TOXIC 
DISEASES AFFECTING ANIMALS. 
The COE research efforts are housed mainly in the Clyde M. York Veterinary 
Medical Teaching Hospital. This building which also contains clinical and teaching 
facilities faces a severe space shortage. While other collaborative research space is 
located in McCord Hall (Animal Science), Walters Life Science Building (Microbiology), 
and at The University of Tennessee Medical Center and Memorial Research Hospital 
(Medical Biology), research space everywhere is a premium. Long-term plans forecast a 
solution for this problem. However, in the short-term reorganization, and minor 
renovation are the stop gap measures. Research laboratories are mulituser and generally 
organized around specific research approaches and are usually shared among different 
faculty with similar interests. Each laboratory contains state-of-the-art equipment 
necessary for conducting high quality research. While the past several years have been 
difficult ones from a fiscal standpoint and little funds have been available for the 
expansion of facilities, the College this past year did undertake the renovation of a 
laboratory to provide an up-to-date in Y.i1m toxicology laboratory COE funds provide the 
new equipment for this facility. It was felt that this was pivotal to several of our younger 
faculty and was part of the Center's commitment to the IVTT group. 
GOAL 8: 	 To DISSEMINATE THROUGH THE EXTENSION SERVICE THE PRACTICAL 
INFORMATION REQUIRED TO REDUCE THE INCIDENT OF LIVESTOCK DISEASES. 
UTCVM has been featured in several publications over the course of the year. UT 
Agriculture, published by the Institute of Agriculture and encompassing a large statewide 
audience, featured articles by COE personnel. Veterinary Medical Topics, published 
semi-annually by the Extension Service, routinely features articles exploring livestock 
diseases. Regular features appear as well in the two UT alumni publications, Context and 
the Torchbearer. Moreover, COE personnel routinely speak to state commodity groups. 
GOAL 9: 	 To DEVELOP NEW STRATEGIES FOR THE PREVENTION OF DISEASE. 
Several projects whose overall objectives are to determine the factors that induce 
formation, maintenance and disruption of the blood-brain barrier and other organ specific 
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toxicity are being conducted by center members. DR. T. ROWLES has begun developing 
protocols for in Yitm testing and kinetics of neurotoxicants. Cytotoxicity assays in 
endothelial, glial, and neuronal cells were established. Additionally, an in Yi1IQ model of 
the blood-brain barrier is being developed by co-culturing these cell types. Work this 
past year in collaboration with DR. D. FRAZIER suggests the astroglia and brain 
capillary endothelial cells may interact in a complex biochemical network via mediators 
such as cytokines and growth factors to modulate maintenance ofthe barrier. 
Breast cancer is the leading cause of death in women ages 35 to 54. During the 
past year, COE has supported DR. K. HAHN's research project aimed at improving the 
therapeutic efficacy of chemotherapy in the clinical management of advanced stage breast 
cancer. The hypotheses of this study is that the cellular response of normal and malignant 
cells in vitro to alkylating cytotoxic drugs is influenced by differences in oxygenation, 
pH, and glutathione concentration and cytotoxicity can be potentiated by etanidazole 
sensitization. Last years work focused on determining whether differences in 
oxygenation in normal lymphocytes in vitro affected etanidazole sensitization of anti­
neoplastic drugs such as bleomycin, doxorubicin HCI, and cis-diammine-dichloro­
piatinumll. It was concluded that etanidazole sensitizes bleomycin, doxorubicin, and cis­
platin cytotoxicity in hypoxic but not in aerobic Go lymphocytes. Moreover, bleomycin 
and doxorubicin induction of micronuclei in etanidazole-sensitized hypoxic cells and 
non-etanidazole-sensitized aerobic cells appears to be dose-dependent. In contrast, 
cisplatin induction ofmicronuclei does not appear to be dose-dependent. 
GOAL 10: 	To IMPROVE FACILITIES AND EXPERTISE IN ORDER TO PROVIDE IMPROVED 
RESEARCH TRAINING. 
SPECIAL MATERIALS AND EOUIPMENT 
Equipment monies this year were spent on assisting with the establishment of 
IVTT laboratory. This multiuser laboratory will service Center members--DRS. D. 
FRAZIER, K. HAHN, T. ROWLES, and D. WARD. This mainly encompassed upgrade 
tissue culture and chemical handling capabilities. As well, several multiuser pieces of 
equipment were purchased, including a steam sterilization unit housed in the P-3 facility . 
GRADUATE STUDENTS, POST DOCTORAL RESEARCHERS, AND RESIDENTS 
Our training program remains small, but of high quality. DRS. D. BRAIN, D. 
FRAZIER, T. McDONALD, J. OLIVER, S. OLIVER, B. ROUSE, AND E. WILKINSON, each 
had a graduate student and/or post-doctoral researcher supported by the Center. 
An institutional training grant has been resubmitted by DR. D. SLAUSON, 
Department of Pathology. If funded, it will support five graduate students/residents 
11 Programmatic Report 
selected from the Comparative and Experimental Medicine Graduate Program. These 
students will train in the area of "Cellular Pathobiology of Environmental Disease." The 
program will be a collaborative effort between the Department of Pathology and the 
Biology Division at Oak Ridge National Laboratory. The program will seek to produce 
individuals who, by virtue of their training, will be uniquely equipped to address such 
important environmental research priorities as the molecular and genetic basis for 
disease, genetic and membrane events that may control differentiation and development, 
the role of receptor-mediated pathobiology including transmembrane signal 
transduction, molecular mechanisms ofchemical carcinogenesis, and the molecular and 
genetic basis for immunologic susceptibility and predisposition. The graduates of this 
program should then be able to contribute to an enhanced understanding of the 
environmentally-caused disorders of man and other animals, both in terms of the 
morphologic expressions of disease and in terms of its molecular and cellular 
pathogenesis. 
Several young investigators continue to benefit from COE funds. Dr. Huda AI­
Ansari continues her work on the significance of strain variation within the ruminant 
respiratory syncytial viruses. Dr. Steve Kannia is in the third year of his investigations of 
the protozoa Babesia bigmina which effects red blood cells of most domestic animals. 
Dr. Melissa Kennedy is involved with examining the antibody response, viral clearance, 
and clinical parameters associated with cattle vaccinated against bovine viral diarrhea 
virus. Dr. Jill Sackman is working on a novel approach to vascular disease . Dr. Jim 
Strickland has finished his second year on a tall fescue toxicosis project. 
MINORITY RECRUITMENT 
Through our minority internship/residency program, UTCVM has been successful 
in recruiting 5 minorities for the upcoming fiscal year. 
The veterinary internship for African-American High School Students in 
Tennessee, developed with funding provided by a grant from the Tennessee Higher 
Education Commission, is now in its second year. This program is very competitive with 
applicants for the eight funded slots. 
The Minority High School Apprentice Program sponsored by the National 
Institutes of Health is currently in its 13th year. It is directed by a Center member DR. T. 
SCHULTZ. 
COLLABORATIVE RESEARCH PROJECTS 
Collaborative research projects continue to be a hallmark of Center personnel, 
especially those in the GFMG group. The role of genotype genomic imprinting and sex 
hormones in platelet and megakaryocyte production is the topic of a new collaboration 
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between DR. T. McDoNALD and Dr. Carl Jackson of St. Judes Medical Center in 
Memphis. 
DR. L. MUNSON continues her collaborations with the University of Washington, 
Seattle to evaluate placental development in the Patch mouse. Molecular techniques are 
being used to identify homozygous mutant embryos so that the development of their 
placenta can be evaluated. 
DR. R. SHULL continues his long-standing collaboration with Dr. Elizabeth 
Neufeld of the University of California at Los Angeles. This work involves the 
development and evaluation oftechniques in gene therapy. 
In collaboration with Dr. Ellis Avner of the University of Washington, Seattle, 
DR. E. WILKINSON is characterizing the kidney cells involved in the production of the 
lesions in the Tg737 mice. In collaboration with Dr. Steve Reeders of Howard Hughes 
Medical Institute, Yale University, Dr. Wilkinson is examining the structure of the Tg737 
gene in over 100 human families with autosomal recessive polycystic kidney disease. In 
addition, Dr. Wilkinson has a collaborative study with Dr. Greg Dressler of the National 
Institutes of Health (NIH). This project examines the nature of the congenital nephrotic 
syndrome in PAX-2 transgenic mice. Dr. Wilkinson's laboratory previously established 
cultures of liver and kidney cells from Tg737 mice. To these have been added several 
lines of liver cells and have been developed from mice with different genetic 
backgrounds. Cooperative efforts between Oak Ridge National Laboratory and Proctor & 
Gamblefurther characterize the putative liver stem cells ofthese cultures. 
Collaborative work is not limited to the GFMG group. DR. T. SCHULTZ of the 
IVTT group and researchers at the School of Pharmacy of John Moores-Liverpool 
University in England are working on modeling toxicity of bioreactive toxicants. 
Bioreactive toxicants are characterized by having strong stereo-electronic interaction 
which appear to be best quantitated by molecular orbital quantum chemical parameters. 
Moreover, Dr. Schultz in conjunction with Dr. Ovanes Mekenyan of the Higher Institute 
of Chemical Technology, Bourgas, Bulgaria is examining a "dynamic" approach to 
quantitative structure-activity relationships. By using high speed computers, they 
develop thousands of three-dimensional conformers for a single two-dimensional 
molecular structure. They are evaluating which conformers best model the activity ofthe 
organic chemical. 
GOAL 11: To DEVELOP INNOVATIVE APPROACHES TO THE TREATMENT OF HUMAN 
DISEASE. 
During the past year, COE provided support for a post-doctoral fellow to work 
with DRS. D. FRAZIER and DR. T. ROWLES. The project looked to the development of 
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cell culture protocols, singly and in co-culture, as a means to evaluate organ specific 
toxicity of chemicals. Specifically neuroblastoma cells, brain capillary endothelial cells 
astrocytes and kidney tubule cells. COE continues to provide support for two doctoral 
students. The projects they are working on are complementary to others being worked on 
by the IVTT group. 
Earlier work by DR. T. McDoNALD showed that thrombopoietin significantly 
increases megakaryocyte sizes and platelet counts of sublethally irradiated mice, 
indicating that thrombopoietin will be useful in treating patients undergoing bone-marrow 
transplantation and/or patients with platelet production problems. Moreover, Dr. 
McDonald's group showed previously that C3H mice have higher average ploidy 
megakaryocytes than other mouse strains tested, but the mode of inheritance of the 
anomaly is unknown. Studies were carried out this past year in an effort to clarify the 
genetics of high ploidy megakaryocytes in C3H mice. They measured megakaryocyte 
DNA content for both male and female offspring from FI, as well as backcross matings. 
The data revealed that polyploidy megakaryocytes DNA content distributions of the 
offspring from the matings showed that C3H mice have higher percentage ofhigh ploidy 
megakaryocytes than did all other mice. Also, male mice had significant higher 
percentages of high ploidy megakaryocytes than did female mice. The megakaryocyte 
DNA content for individual offspring of a given backcross appeared to form a single, 
continuous distribution, rather than segregating into 2 distinct groups, suggesting that the 
higher megakaryocyte DNA content of C3H mice is caused by involvement of multiple 
alleles. This conclusion is further supported by their findings that the frequency ofhigh 
ploidy megakaryocytes among offspring of the various matings was related to the 
proportion ofC3H genotype contributed by the parents. 
DR. B. ROUSE continues his work to design delivery vehicles that optimize 
induction of cytotoxic T lymphocytes with viral proteins and peptides. This program, in 
collaboration with Dr. Leaf Huang, University of Pittsburgh, uses liposomes as the agent 
carriers. This approach may prove a means to prevent virus infections in humans. 
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II. BENCHMARKS 
TABLE 1. CENTER OF EXCELLENCE IN LIVESTOCK DISEASES AND HUMAN HEALTH 

BENCHMARKS OF FACULTY ACCOMPLISHMENTS 

FACULTY MEMBERS ASSOCIATED 

WITH THE CENTER OF EXCELLENCE 

YearS Year 6 Year 7 YearS Year 9 Year 10 
(Final Year of (Year 01 as (Year 02 as (Year 03 as (Year 04 as (Year 05 as 
Initial Commitment) Accomplished Accomplished Accomplished Accomplished Accomplished 
Center) Center) Center) Center) Center) Center) 
1991-92 1992-93 1988-89 1991-92 1992-93 1994-95 
~ 
~Target Actual Avg Actual Avg Actual Avg Actual Avg Actual Avg Actual Avg 
(':>A. 	NUMBERS OF 
~ 
;:s-. 
1. ARTICLES 	 74 (3.22) 68 (2.62) 97 (3.73) 83 (4 .37) 78 (3.90) 95 (5.00) ~ ~ 
"'l 
;>;0­2. 	 BOOKS OR BOOK CHAPTERS 7 (0.30) 17 (0.65) 14 (0.54) 6 (0.32) 7 (0.35 I 9 (0.47) I c., 
PUBLISHED 
3. 	 PUBLISHED PROCEEDINGS ~ (.QJt1) n (1A2) 42 (1.&2) 24 (1 .26) 11 (0.85) 11 @..5..8.). 
TOTAL PUBLICATIONS: 2.82 102 (4.43) 122 (4 .69) 153 (5.89) 113 (5.95) 102 (5.10) 104 (5.47) 
I 
B. *NUMBER OF INVITED 
PARTICIPATIONS AT: 
1. 	REGIONAL MEETINGS 0.50 36 (1 .56) 19 (0.73) 28 ( 1.08) 13 (0.68) 15 (0.75) 18 (0.95) 
2. 	NATIONAL MEETINGS 1.25 55 (2 .39) 28 (1.08) 44 (1 .69) 36 (1 .89) 47 (2 .35) 47 (2.47) 
C. 	 ABSTRACTS 0.30 33 (1.43) 66 (2 .54) 48 (1.85) 47 (2.47) 53 (2 .65) 55 (2 .89) 
NUMBER OF FACULTY INCLUDED 
IN CENTER 23 26 26 19 20 19 
NUMBER OF VISITORS 11 10 17 	 17 12 12 13 
-U1 
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TABLE 2 . 

RESEARCH PROJECTS FUNDED EXTERNALL Y 

REPORT PERIOD 1993-94 

PROJECT DIRECTOR 
BOCHSLER, P. N. 
Bovine Lipopolysaccharide Binding 
Protein and Mechanisms of 
Macrophage Activation 
BOCHSLER, P. N. 
Molecular Basis ofEndothelial Cell 
Sensitivity to Lipopolysaccharide 
BOCHSLER, P. N. 
The Bovine CD 14 Receptor: A Link in 
Endotoxin-mediated Macrophage Activation 
BRIAN, D. A. 
Coronavirus Structure and Replication 
BRIAN, D. A. 
Mechanism(s) ofCoronavirus 
RNA Replication and Packaging 
FRAZIER, D. L. 
Transport ofPhotosensitizers Across the 
Blood Brain Barrier 
FRAZIER, D. L. 
Analysis ofthe Photosensitizer HPPH 
GODKIN, J. D. 
Retinoid Binding Proteins and 
Receptors in Bovine Placental Development 
HAHN,K.A. 

FRAZIER, D. L., Co-investigator 

Phase II Evaluation ofDoxorubicin in the Cat 
HAHN,K. 

SCHULLER, H. M., Co-investigator 

Contract--B859-035 Treatment ofDogs with 
Osteosarcoma 
MCDONALD, T. P. 
Contract--Development ofAssays for 
Thrombopoietin 
SOURCE 

EXPENDITURES 

USDA 

9/1 /91-8/31/93 

(Extension to 8/31/94) 

USDA 

911 5/92-9/30/94 

USDA 

911 5/92-9/30/94 

NIH 
911/89-8/31194 

USDA 

911 5/92-9/30/95 

Beckman Laser 

SDI-MFEL Consortium 

711/93-6/30/94 

Beckman Laser 

Institute & Med Ctr 

9/1/93-3/1/94 

USDA 

911/93-8/31/96 

AAHA 

7/1/94-6/30/96 

BYK Gulden 

Pharmaceuticals 

1/1/93-12/31/95 

Genentech 

3/1/88-2/28/93 

(Extension to 2/28/95) 

TOTAL AMOUNT ESTIMATED 
AWARDED EXPENDITURES 
7-1-93/6-30-94 
140,000 --------------- 21 ,740 
95,000 --------------- 47,496 
150,000 --------------- 75,000 
549,224 --------------1 I 1,773 
200,000 --------------- 66,660 
15,000 --------------- 15,000 
15,000 --------------- 15 ,000 
212,000 --------------- 52,999 
10,000 ---------------------- 0 
63,890 --------------- 21 ,300 
175,832 --------------- 25,116 
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PROJECT DIRECTOR 
McDoNALD, T. P. 
Performance ofAssays for Thrombopoietin 
MCDONALD, T. P. 
Characterization of Thrombopoietin 
McDoNALD, T. P. 
Thrombopoietin: Immunoassay & 
Characterization 
McDoNALD, T. P. 
Purchase of: Nikon Labophot Fluvor 
Dual Filter Microscope 
MILLER, M. S. 
Role ofOncogenes in Transplacental 
Lung Carcinogenesis 
MUNSON, L. 
The Pathological Effects ofMelengestrol 
Acetate in Captive Wild FeUds 
MUNSON, L. 
Effects ofProgestagen Contraceptives on the 
Uterus and Mammary Glands ofExotic FeUds 
MUNSON, L. 
Continuing Safety Assessments of 
Contraceptives for Non-domestic FeUds 
OLIVER, S. P. 
Mastitis Research 
OLIVER, S. P. 
Mastitis Research 
OLIVER, S. P. 
Immunization ofdairy cows against 
StreDtococcus ~: Efficacy ofan 
Experimental Vaccine during the 
Nonlactating Period 
OLIVER, S. P. 
Selenium and Vitamin E in 
Disease Resistance 
SOURCE 

EXPENDITURES 

Genentech 

3/1/88-7/31/93 

(Extension to 2/28/95) 

AMGEN 

10/1 /92-12/31 /95 

NIH 
12/1/88-11/30/93 
(Extension to 11/30/94) 
NHLBI Small 
Instrumentation Program 
8/1/93-7/31/94 
NIEHS 
5/1/94-4/30/97 
AAZPA 
Conservation Center 
10/1/92-9/30/93 
Nixon Griffis Fund 
3/1/91-2/28/94 
AAZPA 
Conservation Center 
3/14/94-3/14/9 5 
AIcide Corporation 
12/90-12/94 
H. B. Fuller Co. 
4/91-12/94 
Upjohn Company 
1991-1994 
BASF 
1992-1994 
TOTAL AMOUNT ESTIMATED 
AWARDED EXPENDITURES 
7-1-93/6-30-94 
112,700 --------------- 16,104 
73,671 --------------- 22,668 
548,681 --------------- 81 ,837 
22,818 --------------- 22,818 
343,804 --------------- 22,402 
37,807 -----------------9,453 
2,843 ------------------- 632 
38,087 --------------- 11,109 
57,752 --------------- 14,438 
31,778 -----------------8,664 
54,225 --------------- 14,056 
17,000 -----------------5 ,000 
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PROJECT DIRECTOR 
OLIVER, S. P. 
Use ofGenetic Markers as Indicators 
ofMastitis Resistance and Milk 
Production in Jersey Cattle 
OLIVER, S. P. 
Intramammary infusion ofAlcide for 
treatment ofclinical mastitis in dairy cows 
OLIVER, S.P. 
Macrophage phagocytosis of 
Streptococcus uberjs 
POTGIETER, L. 
SigniJicance ofStrain Variation within the 
Ruminant Respiratory Syncytial Virus 
POTGIETER, L. 
Cloning and Sequencing ofBRSV G 
Glycoprotein and Detection ofStrain 
Divergence 
ROUSE, B. T. 
Immunity Mechanisms in Herpes Virus Infections 
ROUSE, B. T., Advisor for D. Bouley 
Herpetic Stromal Keratitis Pathogenesis: 
An Animal Model 
ROUSE, B. T. 
Mechanisms in Herpetic Stromal Keratitis 
ROUSE, B. T. 
Liposome Microencapsulation of Vaccine 
Antigens 
ROUSE, B. T. 
Mucosal Immunity in Control ofHerpetic 
Infection 
ROUSE, B. T. 
Herpes ZosteriJication 
ROWLEST. K. 
Characterization Isolated Rodent 
Microvesselsl Astrocytes Co-cultures 
, SOURCE 
EXPENDITURES 
Amer Jersey 

Cattle Club 

1993-94 

A\Cide Corporation 

1993-94 

Upjohn Company 

1994-95 

USDA 

9/1 /93-8/3 1/95 

USDA Special Grant 

8/1 /90-7/3 1/93 

NIH 

5/1 /89-4/30/94 

NIH Training Grant 

7/1 /93-6/30/95 

National Eye 

Institute (NIH) 

9/30/92-9/29/97 

NIAID 

611 /90-5/31/95 

NIAID 

811 /93-7/31/96 

SmithKline Biological 

12/15/89-12/31/94 

Environmental Protection 

Agency (EPA) 

417/93-4/6/95 

TOTAL AMOUNT ESTIMATED 
AWARDED EXPENDITURES 
7-1-93/6-30-94 
6,000 --------- 3,000 
14,167 --------- 7,085 
8,000 --------- 4,000 
123,3 1 0 -------- 5 1 ,380 
149,974 --------- 4,165 
1,130,370------ 197,670 
110,168 -------- 35,300 
774,745 ------ 200,217 
828,289 ------ 166,235 
562,404 ------ 160,534 
124,746 --------------- 25,000 
9,484 -----------------4,740 
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PROJECT DIRECTOR 
ROWLEST. K. 
Evaluation ofRenal and Neural 
Function in Diving Mammals using in 
vitro and in vivo Techniques 
SCHULLER, H. M. 
Mechanisms ofNeuroendocrine Lung 
Carcinogenesis by Nitrosamines 
SCHULLER, H. M. 
Characterization ofInduced Neuroendocrine 
Lung Cancer 
SCHULLER, H. M. 
Contract--Testing ofAnti-carcinogenic 
Effects ofNiguldipine 
SCHULTZ, T. W. 
Photo-inducted Toxicity ofSubstituted 
Anthracenes 
SHULL, R. 
Molecular Study ofMPS I: Gene Therapy 
in a Canine Model 
SLAUSON, D. O. 
Leukocyte Function and Host Defense 
in Developing Calves 
SLAUSON, D., Advisor for D. Dean 
Signaling Pathways in LPS-Stimulated 
Lung Macrophages 
WILKINSON, J. E. 
Directed Expression ofthe Agouti Gene 
Product in Transgenic Mice: A Potential 
Model for Obesity 
WILKINSON, J. E. 
Molecular Genetics ofP KD in the 
Transgenic TG737 Mouse 
WILKINSON, J. E. 
Immunobiology ofthe Scurfy Mouse 
SOURCE 

EXPENDITURES 

Office of Naval 
Research 
6/1/94-5/31/95 
Shannon A ward 
Institute (NIH) 
9/1 /91-8/31/93 
National Cancer 
Institute (NIH) 
2/7/92-1/31/95 
8yk Gulden 
Pharmaceuticals 
3/1/88-12/31/94 
University of Minnesota 

1/15/94-1114/95 

NIH 

8/1 /92-7/31196 

USDA Competitive 

8/15/90-8/30/92 

(Extension to 8/30/93) 

NIH Training Grant 

11130/91-11/30/94 

G1axo Inc . 

10/1 /93-9/30/96 

NIH 

9/30/92-9/29/95 

NIH 

9/30/92-5/31/95 

TOTAL 

TOTAL AMOUNT ESTIMATED 
A WARDED EXPENDITURES 
7-1-93/6-30-94 
36,833 -----------------3,069 
100,000 -----------------8,332 
464,975 --------------170,144 
382,925 --------------- 52,497 
9,525 -----------------4,700 
1,001,653 --------------123,342 
120,000 --------------- 35,499 
97,500 --------------- 33,800 
672,890 --------------- 72,747 
444,816 --------------160,944 
633,875 --------------249,083 
$2.454,748 
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III. PLANS FOR NEXT YEAR 
CARCINOGENESIS AND DEVELOPMENTAL THERAPEUTICS GROUP 
DR. H. SCHULLER will continue to pursue research in lung carcinogenesis. In particular, 
she will expand her studies in neuroendocrine tumors and anti-cancer therapeutics of the 
calcium channel blocker, Dexniguldipine. 
DR. M. MILLER's goals for the coming year are to work with Dr. D. Schaeffer in 
performing i.p. injections in pregnant mice and establish the breeding colony needed for his 
project on the role of onocogenes in transplacental carcinogenesis. Moreover, he will be 
standardizing the research protocol to extract DNA from paraffin embedded mouse tissues and 
begin the molecular biology analyses. 
This coming year, DR. K. HAHN will continue his work, therapeutic efficacy of 
chemotherapy. Assisted by support from Bristol Laboratories and the National Cancer 
Institute with donated drugs, he will seek to determine if differences in cellular pH and/or 
glutathione concentrations in normal lymphocytes or mammary carcinoma cells in vitro 
quantitatively affect etanidazole (SR-2508), an oxygen-mimetic nitroimidazole, sensitization 
of cytotoxicity to selected chemotherapeutics including bleomycin, cisplatin, and doxorubicin. 
GROWTH FACTORS AND MOLECULAR GENETICS GROUP 
DR. E. WILKINSON plans a number of functional studies on the cultured Tg737 kidney 
cells to further define their characteristics. Further, the Tg737 gene will be replaced in the 
cultured cells by standard methods to precisely determine the effect of the Tg737 gene on cell 
structure and function. Additionally, they will use mammalian expression vectors with 
inducible promoters to turn the Tg737 gene on and off and study the function . A number of 
vectors containing mutations in specific regions of the Tg737 protein will be engineered as a 
basis for further studies of the structure and function of the protein. Finally, a number of in 
vivo studies using the cultured liver cells will be conducted. 
DR. R. SHULL will continue the gene therapy and recombinant enzyme trials. 
Modifications of existing in vitro techniques for transferring the gene for the missing enzyme 
to several cell types will be investigated. In addition to bone marrow cells, he will attempt to 
use skin fibroblasts and myoblasts from skeletal muscle as targets for gene therapy. These 
cell types have the advantage of easier transfection with retroviral vectors and have been 
shown to secrete lysosomal enzymes. One or more dogs with MPS I will also be treated with 
injectible enzyme in trials lasting 6-12 months. The goal will be to see if beneficial effects 
can be realized in a broader range of tissues than in the first attempts that only lasted 13 
weeks. 
21 Plans for Next Year 
Work planned for the coming year in DR. T. McDoNALD' s laboratory focuses primarily 
on investigating the mode of inheritance of the higher degree of megakaryocyte 
polyploidization in C3H mice. They will also examine the effects of large doses of TPO on 
platelet production in mice, complete work on the effects of vincristine on megakaryocyte 
complexes and other cytoplasmic abnormalities in megakaryocytes and platelets of rats, and 
investigate the role of genotype genomic imprinting and sex hormones in platelet and 
megakaryocyte production. 
During the next fiscal year, DR. C. MENDIS-HANDAGAMA will continue to focus her 
efforts on understanding the mechanisms involved in movement of peroxisomes towards 
mitochondria for cholesterol delivery. 
DR. J. MERRYMAN will join the GFMG group this coming year. Her work will focus on 
understanding the control of proliferation in cancer cells. Control of cellular proliferation is 
exerted at the G 1 IS interface of the cell cycle by certain growth factors, cyclin-dependent 
protein kinases, and nuclear phosphoproteins such as the product of the retinoblastoma gene, 
p105-Rb. Parathyroid hormone-related protein (PTHrP) is a newly identified calciotropic 
hormone that causes the important paraneoplastic syndrome humoral hypercalcemia of 
malignancy. In addition PTHrP has also been shown to be an autocrinelparacrine factor in 
control of cellular proliferation in normal and malignant cells. The purpose of this 
investigation is to evaluate human tumor cell lines for production of PTHrP and expression of 
PTHrP receptors, and to examine the effects of PTHrP on cellular proliferation. These 
investigations will prove useful in understanding control of proliferation in neoplastic cells, a 
timely and important topic in the field of cancer biology, and will serve as a starting point for 
more in-depth investigations in this critical area of cancer research. 
DR. L. MUNSON will continue her research on the role of PDGFs in bovine placental 
growth and the Patch mouse model. Studies examining the interaction of PDGF and retinoic 
acid will be continued. Moreover, collaborations with the UTK Medical Center include 
molecular analysis of normal, endometriotic, and malignant human endometrial epithelium to 
determine if PDGF -a and PDGF -b receptors are present as well as research into the effects of 
POGF in endometrial hyperplasia and neoplasia. 
DR. J. GODKIN plans to complete his investigations on the role of retinoids, binding 
proteins and receptors in embryonic development and uterine function. Work will continue 
on interaction of transforming growth factors and retinoids in uterine function and embryonic 
development. He also proposes to examine the role of retinoids in ovarian and oviduct 
function. 
IN VITRO TOXICOLOGY AND TOXICOKINETICS GROUP 
DR. T. SCHULTZ will continue his studies on predictive toxicology. Work will involve 
toxicity testing, molecular descriptor evaluation, and structure-toxicity relationship 
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development of bioreactive chemicals. Efforts will center on the development and validation 
of a computer aided structure evaluation (CASE) approach to identify toxicophores associated 
with bioreactivity. 
For DR. T. ROWLES, next year' s work will involve further development of protocols for 
the in vitro assessment of neurotoxicity and testing of selected toxicants. 
DR. D. FRAZIER will be working to develop an in vitro model of the kidney. This model 
will be used for evaluation of transport and cytotoxicity of environmental toxicants and cancer 
chemotherapeutics. 
DR. D. WARD, a new member of the Center this coming year, in conjunction with DR. 
SCHULTZ will continue his work begun in March of this year on the development and testing 
of blood ocular barriers. 
INFECTIOUS DISEASES AND POPULATION MEDICINE GROUP 
Work in DR. L. POTGIETER'S laboratory will continue on several projects .. They will 
continue to investigate the protective nature of the structural proteins of BVDV individually 
and in combination with one another, as well as continue efforts to develop economical and 
accurate diagnostic assays. In the next year, they will also continue work on ruminant RSV. 
Specifically, they plan to identify subgroups within the RSVs using monoclonal antibodies in 
an ELISA system of identification and to assess the significance of strain variation within the 
RSV s. Moreover, they will be working on projects that involve immunostimulatory effects of 
ivermectin in dogs, immunology of dogs with generalized demodicosis, and development of 
improved methods for detecting feline immunodeficiency virus. 
DR. S. OLIVER and his co-workers will continue to focus on development of RAPD 
fingerprinting which has the potential to be a routine bacterial species identification method. 
They plan on evaluating commercially available oligonucleotide primers and develop a 
tentative species identification scheme. 
DR. J. OLIVER and associates will, in the next year, further characterize specific alkaloid 
effects on vascular biogenic amine receptors following chronic alkaloid infusion and 
endothelial cells. They also will examine adrenal function in cattle on endophyte-infected 
pasture. It is hoped that this next year will also see patent approval for an anti-fescue 
toxicosis vaccine. 
DR. D. BRIAN' S research over the next 12 months will focus on developing the 
coronavirus sUbgenomic replicon as a delivery vehicle for stimulating mucosal immunity and 
as a vehicle for other direct-hitting antiviral molecules. 
INFLAMMA TION AND HOST DEFENSE GROUP 
DR. P. BOCHSLER will continue to investigate factors involved in the response of cattle 
to endotoxin produced by gram-negative bacteria. Their plans include further studies with 
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bovine lipopolysaccharide-binding protein that they have isolated and defining methods for 
the identification of the bovine CD 14 receptor molecule. This receptor appears to be 
important in the response of cattle to endotoxin. In addition, they will examine the roles of 
interleukin-6, superoxide anion, and nitric oxide in bovine inflammation and host defense. 
Studies of endotoxin and important bovine immunoregulatory molecules will yield a better 
understanding of the bovine response to pathogens, and will eventually lead to improved . 
methods of disease prevention and therapy. 
The specific goals for DR. B. ROUSE include working on in sill! hybridization methods in 
order to further characterize the cytokine profile (gene expression) and viral gene expression 
during the course of HSK. This is to identify and localize the cells involved in the 
immunopathology of HSK. Towards this end, he and his associates have developed specific 
probes for the detection of viral genes, inflammatory cytokine genes and T cell derived 
cytokine genes. Studies will also be conducted in an effort to detect selected cytokines and 
genes of cornea obtained during various stages of the development of HSK. 
During the next year DR. D. SLAUSON will continue to dissect the signaling pathways 
used by LPS and LPS/LBP complexes for procoagulant induction and TNF -a release in 
bovine lung macrophages with special attention directed at the potential role of a G-protein 
linked receptor in the proximal pathway and a C-kinase as a terminal activator. 
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Curriculum Vitae for Joyce I. Merryman 
Position Title 	 Birthdate 
Joyce Irene Merryman Assistant Professor 	 October 28, 1953 
Education Deuee 	 Field of Study 
Hocking Technical College A.D. Nursing 1978 Nursing 
The Ohio State University B.S. 1983 Zoology 
The Ohio State University D.V.M. 1987 Veterinary Medicine 
The Ohio State University Ph.D. 1993 Pathobiology 
Professional Experience 
1993-Present 	 Assistant Professor, Department of Pathology, University of Tennessee College of 
Veterinary Medicine. 
1989-1993 	 National Research Service Award, National Cancer Institute, studying the role of humoral 
factors in the pathogenesis of humoral hypercalcemia of malignancy. 
1989-1993 	 Graduate Research Fellow, The Ohio State University, Department of Veterinary 
Pathobiology pursuing advanced research training leading to completion of the Ph.D degree 
in Experimental Pathobiology. 
1987-1989 	 Schering Plough Corporation Fellow/Resident, The Ohio State University, Department of 
Veterinary Pathobiology pursuing research training leading to a Ph.D. degree in 
Experimental Pathobiology and specialty training leading to Board Certification by the 
American College of Veterinary Pathologists. 
1985-1986 	 Student Research Associate, The Ohio State University, Department of Veterinary 
Pathobiology, in the laboratories of C.C. Capen and T.J. Rosol 
1980-1985 	 Registered Nurse, Grant Hospital, Columbus, Ohio, Surgical and Trauma Critical Care 
1978-1980 	 Registered Nurse, The Ohio State University Hospitals, Cardiovascular Surgical Nursing 
Professional Teachin& Experience 
1987 -1992 	 Graduate Teaching Associate in applied Veterinary Pathology, (Necropsy training for 
professional students). 
Graduate Teaching Associate in Dermatopathology (Dermatology core curriculum course 
for professional students) . 
1991 
Professional Honors 
National Research Service Award, National Cancer Institute, "Humoral Factors and Hypercalcemia of 
Malignancy", 1989-1992 
Schering Plough Corporation Fellow, 1987-1989 
Finalist, Graduate Research Forum, The Ohio State University, 1989 
Phi Zeta National Veterinary Honorary, 1986-present 
Phi Zeta Research Award, The Ohio State University, College of Veterinary Medicine, 1987 
Graduated summa cum laude, The Ohio State University, College of Veterinary Medicine, 1987 
Second Place, American College of Veterinary Pathologists Young Investigator Award, 1993 
Professional Societies 
Phi Zeta, 1986-present 
American Veterinary Medical Association, 1981-present 
American Society for Bone and Mineral Research, 1989-present 
Publications in Peer-Reviewed Journals 
Merryman, J.I., Rosol, T.J., Brooks, C.L., and Capen, C.C.: Separation of parathyroid hormone-like 
activity from transforming growth factor (TGF) -a and -6 in the canine adenocarcinoma (CAC-8) 
model of humoral hypercalcemia of malignancy. Endocrinology, 124:2456-2463, 1989. 
Rosol, T.J., Merryman, J.I., Nohutcu, R.M., McCauley, L.K., and Capen, C.C.: Effects of 
transforming growth factor-a on parathyroid hormone- and parathyroid hormone-related protein­
mediated bone resorption and adenylate cyclase stimulation in vitro. Domestic Animal 
Endocrinology 8:499-507, 1991. 
McCauley, L.K., Rosol, T.J., Merryman, J.I., and Capen, C.C.: Parathyroid hormone-related protein 
binding to human T-celllymphotropic virus type I-infected lymphocytes. Endocrinology 130:300­
306, 1992. 
Rosol, T.J., Steinmeyer, C.L., McCauley, L.K., Merryman, J.I., Werkmeister, J.R., Grone, A., 
Weckman, M.T., Swayne, D.E., and Capen, C.C.: Characterization of chicken polyclonal anti­
peptide antibodies specific for human parathyroid hormone-related protein (1-36). VeterinaIY 
Immunology and Immunopathology 35:321-338, 1993. 
Merryman, J.I., Rosol, T.J., Werkmeister, J.R., McCauley, L.K., Suter, M.M., and Capen, C.C.: 
Regulation of parathyroid hormone-related protein production by a squamous carcinoma cell line 
in vitro. Laboratory Investigation, 69:347-354, 1993. 
Fenger, C.K., Bertone, J.J., Biller, D., Merryman, J.1.: Generalized medullary infarction of the long 
bones in a horse. Journal of the American Veterinary Medical Association, 202:621-623, 1993. 
Werkmeister, I.R., Merryman, J.I., McCauley, L.K., 1, Horton, J.E., Capen, C.C., Rosol, T.J.: 
Parathyroid hormone-related protein production by normal human keratinocytes in vitro. 
Experimental Cell Research, 208:68-74, 1993. 
Merryman, J.I., Rosol, T.J., Capen, C.C.: Effects of gallium nitrate in nude mice bearing a canine 
adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy. Journal of Bone and 
Mineral Research, 9:725-732, 1994. 
Merryman, J.I., Dewille, J ., Werkmeister, J.R., Capen, C.C., Rosol, T.J.: Effects of transforming 
growth factor-beta on parathyroid hormone-related protein production and RNA expression by a 
squamous carcinoma cell line in vitro. Endocrinology, 134:2424-2430, 1994. 
Okada, H., Merryman, J.I., Rosol, T.J., Capen, C.C.: Effects of humoral hypercalcemia of malignancy 
and gallium nitrate on thyroid C-cells in nude mice: immunohistochemical and ultrastructural 
investigations. Veterinary Pathology, 31 :349-357, 1994. 
Okada, H., Merryman, J.I., Rosol, T.J., Capen, C.C.: Ultrastructural and histomorphometric evaluations 
of the effects of gallium nitrate on bone in nude mice bearing a canine adenocarcinoma (CAC-8) 
model of humoral hypercalcemia of malignancy. Veterinary Pathology, In Press, 1994. 
Grooters, A.M., Miyabayashi, T., Biller, D.S., Merryman, J.: Sonographic appearance of uremic 
gastropathy in four dogs. Veterinary Radiology and Ultrasound, 65:35-40, 1994. 
Capen, C.C., Okada, H., Merryman, J.I., Rosol, T.J.: Effects of gallium nitrate in nude mice bearing 
a canine adenocarcinoma model of humoral hypercalcemia of malignancy: biochemical, 
histomorphometric, and ultrastructural investigations. Journal of Bone and Mineral Metabolism, 
In Press, 1994. 
Published Abstracts 
Rosol, T.J., Capen, C.C., Merryman, J.I., and Carpenter, G.: Inhibition of in vitro bone resorption by 
a hypercalcemia adenocarcinoma (CAC-8) by a PTH receptor antagonist (8, 18Nle, l4Tyr 
bPTH[3-34]). In: Abstracts of American Society of Bone and Mineral Research Meetings, 
Indianapolis, IN, June 1987; and published in Journal of Bone and Mineral Research 2 [Suppl 1], 
(1987): 86A. 
Merryman, J.I., Rosol, TJ., and Capen, C.C.: Transforming growth factor activity in a canine tumor 
line derived from an anal sac adenocarcinoma maintained in nude mice. In: Abstracts of Annual 
Phi Zeta Research Day, Columbus, 15 May 1987. 
Rosol, T.J., Capen, C.C., Merryman, J.I., Danks, J.A., Hayman, J., Ebeling, P.R., and Martin, T.J.: 
Investigations on parathyroid hormone-related protein in canine anal sac adenocarcinoma and 
infusion of PTHrP in nude mice. In: Abstracts of 39th Annual Meeting of American College of 
Veterinary Pathologists, Kansas City, MO, 31 October-4 November, 1988, p. 13. 
Merryman, J.I. and Capen, C.C.: Separation of parathyroid hormone-like activity from transforming 
growth factors-a and -B in a canine adenocarcinoma (CAC-8) model of cancer-associated 
hypercalcemia. In: Abstracts of 14th Annual Forum for Graduate Students in the Biological and 
Health Sciences, The Ohio State University, 1989. 
Merryman, J.I., Rosol, T.J., Capen, C.C.: Separation of parathyroid hormone-like activity from 
transforming growth factor (TGF)-a and -B in a canine adenocarcinoma model (CAC-8) of 
humoral hypercalcemia of malignancy (HHH). In: Abstracts (No. 805) of American Society of 
Bone and Mineral Research/International Conference on Calcium Regulating Hormones First Joint 
Meeting, Montreal, Quebec, 9-14 September 1989, and published in Journal of Bone and Mineral 
Research 4 (Suppl. 1): S319, 1989. 
Merryman, J.I., Rosol, T.J., and Capen, C.C.: Separation of parathyroid hormone-like activity from 
transforming growth factors-a and -B in a canine adenocarcinoma model of humoral hypercalcemia 
of malignancy. In: Proceedings of 40th Annual Meeting of American College of Veterinary 
Pathologists, Baltimore, MD, 1-4 November 1989, p. 45. 
Rosol, T.J., Merryman, J.I., Martin, S.L., and Capen, C.C.: Adenocarcinoma derived from specialized 
cutaneous diverticula (anal sac) in dogs associated with persistent hypercalcemia: Clinical, 
pathologic, ultrastructural, immunohistochemical, and in vitro studies. In: Abstracts of First 
World Congress on Veterinary Dermatology, 28-30 September, 1989, Dijon, France, p. 28; and 
published in Advances in Veterinary Dermatology, Vol. I. (C. von Tschamer and R.E.W. 
Halliwell, Editors), Bailliere Tindall, London, 1990, p. 445. 
Rosol, T.J., Merryman, J.I., McCauley, L.K., Steinmeyer, C.L., Swayne, D., and Capen, C.C.: 
Characterization of polyclonal and monoclonal antibodies to parathyroid hormone-related protein. 
In: Abstracts (No. 481) of American Society for Bone and Mineral Research, Atlanta, GA, 28-31 
August 1990; and published in Journal of Bone and Mineral Research 5 (Suppl. 1, 1990): p. S194. 
Rosol, T.J., Merryman, J.I., McCauley, L.K., and Capen, C.C.: Effects of transforming growth factor 
alpha on parathyroid hormone- and parathyroid hormone-related protein-mediated bone resorption 
and adenylate cyclase stimulation in vitro. In: Proceedings of 41st Annual Meeting of American 
College of Veterinary Pathologists, Phoenix, AZ, 10-14 December, 1990, p. 52. 
Rosol, T., Merryman, J., McCauley, L., Werkmeister, J., Grone, A., Steinmeyer, C., Swayne, D., 
Capen, C.: Pathogenesis of cancer-associated hypercalcemia of malignancy: Characterization of 
polyclonal antibodies to parathyroid hormone-related protein in chickens. In: Abstracts of the 
Eighth International Workshop on Vitamin D. Paris, France 5-10 July 1991, p. 51 and Published 
in: Vitamin D - Gene Regulation. Structure-Function Analysis. and Clinical Application. (A.W. 
Norman, R. Bouillon, and M. Thomasset, Editors). Walter de Gruyter, Berlin/New York, 1991, 
pp. 919-920. 
Rosol, T., Merryman, J., McCauley, L., Werkmeister, J., Swayne, D., and Capen, C.: Pathogenesis 
of humoral hypercalcemia of malignancy (HHM): Production of polyclonal antibodies to 
parathyroid hormone-related protein (PTHrP) in chickens. In: Abstracts (No. 187) of 80th 
Meeting of U.S. and Canadian Academy of Pathology, Chicago, 17-22 March, 1991; and 
published in Laboratory Investigation 64, (1991): 33A. 
Werkmeister, J., Rosol, T., McCauley, L., Merryman, J., Horton, J., and Capen, C.: Regulation of 
parathyroid hormone-related protein in normal human keratinocytes. In: Abstracts of 20th Annual 
Meeting of IADRI AADR (International/American Assn. of Dental Research), Acapulco, Mexico, 
17-21 April, 1991; and published in Journal of Dental Research 70, (1991) : 312. 
Merryman, J.I., Rosol, T.J., McCauley, L.K., and Capen, C.C.: Production of parathyroid hormone­
related protein by two human squamous cell carcinoma cell lines in vitro. In: Abstract (No. 594) 
of American Society for Bone and Mineral Research, San Diego, CA, 24-28 August, 1991; and 
published in Journal for Bone and Mineral Research 6, (Suppl. 1, 1991): S232. 
Werkmeister, J.R., Rosol, T.J., Merryman, J.I., McCauley, L.K., Horton, J.E., and Capen, C.C.: 
Regulation of parathyroid hormone-related protein in normal human keratinocytes in vitro. In: 
Abstract (No. 586) of American Society for Bone and Mineral Research, San Diego, CA, 24-28 
August, 1991; and published in Journal for Bone and Mineral Research 6, (Suppl. 1, 1991): S230. 
McCauley, L.K., Rosol, T.J., Lairmore, M.D., Merryman, J.I., and Capen, C.C.: Expression of 
parathyroid hormone-related protein in human T cell leukemia virus type (HTLV-l) infected 
lymphocytes. In: Abstract (No. 568) of American Society for Bone and Mineral Research, San 
Diego, CA, 24-28 August, 1991; and published in Journal for Bone and Mineral Research 6, 
(Suppl. 1, 1991): S226. 
Rosol, T., Merryman, J., McCauley, L. , and Capen, C.: Transforming growth factor-alpha effects on 
parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP)-mediated adenylate 
cyclase stimulation and bone resorption in vitro. In: Abstracts of Eighth International Workshop 
on Vitamin D, Paris, France, 5-10 July, 1991, p. 169. 
Merryman, J.I., Capen, C. C., and Rosol, T.J.: Characterization of polyclonal and monoclonal antibodies 
to parathyroid hormone-related protein (PTHrP). In: OSU Phi Zeta Research Forum, 28 May, 
1991. 
Rosol, T.J., Merryman, J.I., McCauley, L.K., Werkmeister, J.R., Grone, A., Swayne, D., Steinmeyer, 
C., and Capen, C. C. : Characterization of polyclonal antibodies to parathyroid hormone-related 
protein (1-36). In: Proceedings of 42nd Annual Meeting of American College of Veterinaty 
Pathologists, Orlando, FL, 8-13 December, 1991, p. 57. 
Merryman, J.I., Rosol, T.J., Werkmeister, J.R., McCauley, L.K., Suter, M.M., and Capen, C.C.: 
Production of parathyroid hormone-related protein by normal and malignant keratinocytes in vitro. 
In: Proceedings of 42nd Annual Meeting of American College of Veterinary Pathologists, 
Orlando, FL, 8-13 December, 1991, p. 56. 
McCauley, L., Rosol, T., Lairmore, M., Merryman, J., and Capen, C.: Modulation of parathyroid 
hormone-related protein mRNA expression in T-Iymphocytes. In: Abstracts of Annual Meeting 
of American Association of Dental Research, Boston, MA, 11-15 March, 1992; and published in 
Journal of Dental Research 71, (1992): 212. 
Werkmeister, J., Rosol, T., Merryman, J., McCauley, L., Horton, J., and Capen, C.: Regulation of 
parathyroid hormone-related protein (PTHrP) in normal human keratinocytes. In: Abstracts of 
Annual Meeting of American Association of Dental Research, Boston, MA, 11-15 March, 1992; 
and published in Journal of Dental Research 71, 1992: 199. 
Merryman, J.I., Werkmeister, J.R., Rosol, T.J., McCauley, L.K., Suter, M.M., and Capen, C.C.: 
Parathyroid honnone-related protein production and receptor expression by nonnal and malignant 
keratinocytes. In: Abstracts (No. 213) of 81st Meeting of U.S. and Canadian Academy of 
Pathology, Atlanta, GA, 14-20 March, 1992; and published in LaboratOIY Investigation 66, 1992: 
37A. 
McCauley, L., Rosol, T., Lainnore, M., Merryman, J., and Capen, C.: Polymerase chain reaction 
amplification of parathyroid honnone-related protein cDNA from high and low HTLV-l viral 
antigen-positive lymphocytes. In: Abstracts (No. 487) of 81st Meeting of U.S. and Canadian 
Academy of Pathology, Atlanta, GA, 14-20 March, 1992; and published in Laboratory 
Investigation 66, 1992: 83A. 
Werkmeister, J.R., Merryman, J.I., Rosol, T.J., McCauley, L.K., and Capen, C.C.: Parathyroid 
honnone related protein production and receptor expression by nonnal and malignant keratinocytes 
in vitro. In: Abstracts of the XIth International Conference on Calcium Regulating Honnones, 
Florence, Italy, 24-29 April, 1992, and published in: Journal of Bone and Mineral 17(suppl. 1), 
1992, p 101. 
Merryman, J.I., Rosol, T.J., DeWille, J.W., Farmer, S.J., Werkmeister, J.R., Capen, C.C.: Stimulation 
of parathyroid honnone-related protein production by transfonning growth factor-fit in a squamous 
carcinoma cell line. Abstract of the 14th Annual Meeting of the American Society for Bone and 
Mineral Research. Minneapolis. Mn .. 1992, and to be published in Journal of Bone and Mineral 
Research, 1992. 
Werkmeister, J.R., Rosol, T.J., Merryman, J.I., Capen, C.C.: Parathyroid honnone-related protein 
production by nonnal human keratinocytes in vitro is associated with a less differentiated 
phenotype. Abstract of the 14th Annual Meeting of the American Society for Bone and Mineral 
Research. Minneapolis. Mn .. 1992, and published in Journal of Bone and Mineral Research, 1992. 
Merryman, J., Rosol, T., Dewille, J., Farmer, S., Werkmeister, J., Capen, C.: Stimulation of 
parathyroid honnone-related protein production by transfonning growth factor-fit in a canine 
squamous carcinoma cell line. Abstract of the 43rd Meeting of American College of Veterinary 
Pathologists. San Diego. Ca .. 1992, and published in Proceedings of the 43rd Meeting of the 
American College of Veterinary Pathologists. 
Merryman, J.I., Rosol, T.J., Dewille, J.W., Werkmeister, J.R., Capen, C.C.: Effects of transforming 
growth factor-fi on production of parathyroid honnone-related protein production by a squamous 
carcinoma cell line. Abstract of the 82nd Meeting of the US and Canadian Academy of Pathology. 
1992, and published in Laboratory Investigation. 66: 1992. 
Merryman, J.I., Okada, H., Capen, C.C., Rosol, T.J. : Effects of gallium nitrate in nude mice bearing 
a canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy. Abstract of 
the 15th Annual Meeting of the American Society for Bone and Mineral Research. 1993, and 
published in Journal of Bone and Mineral Research, 8:suppll, 1993. 
Okada, H., Merryman, J.I., Rosol, T.J., Capen, C.C.: Effects of cancer-associated hypercalcemia and 
gallium nitrate on thyroid C-cells in nude mice. Abstract of the 15th Annual Meeting of the 
American Society for Bone and Mineral Research. 1993, and published in Journal of Bone and 
Mineral Research, 8: suppll, 1993. 
Grone, A., Merryman, J.I., Werkmeister, J.R., Capen, C.C., Rosol, T.J.: Parathyroid hormone-related 
protein (PTHrP) production in malignant and normal keratinocytes. Abstract of the 44th Meeting 
of American College of Veterinary Pathologists. San Antonio. TIC. 1993, and published in 
Veterinary Pathology, 30:AI55. 
Merryman, J.I., Okada, H., Capen, C.C., Rosol, T.J.: Effects of gallium nitrate in nude mice bearing 
a canine adenocarcinoma model of humoral hypercalcemia of malignancy. Abstract of the 44th 
Meeting of American College of Veterinary Pathologists. San Antonio. TX .. 1993, and published 
in Veterinary Pathology, 30:A77. 
Okada, H., Merryman, J.I., Rosol, T.J., Capen, C.C.: Effects of cancer-associated hypercalcemia and 
gallium nitrate on thyroid C-cells in nude mice. Abstract of the 44th Meeting of American 
College of Veterinary Pathologists. San Antonio. TX .. 1993, and published in Veterinary 
Pathology, 30:AI58. 
Capen, C.C., Okada, H., Merryman, J.I., Rosol, T.J., : Effects of gallium nitrate in nude mice bearing 
a canine adenocarcinoma model of humoral hypercalcemia of malignancy. Abstract of the 3rd 
International Conference on New Actions of Parathyroid Hormone. Tokyo. Japan. 1994, and to 
be published in Proceedings of the 3rd International Conference on New Actions of Parathyroid 
Hormone, 1994. 
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Knoxville, TN 37922 
BIRTHDATE October 23, 1960 
FAMILY Wife - Sherry L. Ward, 
Children - One son, 
AHT 
Garrett D. Ward 
EDUCATION 
Christian Brothers College; Memphis, TN; 1978-1981 
Chemical Engineering Major 
No degree conferred 
Middle Tenn. State University; Murfreesboro, TN; 1981-1982 
Pre-veterinary major 
No degree conferred 
University of Tennessee; Knoxville, TN; 1982-1985 
veterinary Medicine Major 
DVM conferred June 1985 
University of Georgia; Athens, GA; 1986-1989 
Pharmacology major 
PhD conferred June 1990 
PROFESSIONAL ACTIVITIES 
Oct. 1990-present 
Assistant Professor, Dept. of Urban Practice 
College of veterinary Medicine 
University of Tennessee 
Knoxville, TN 37901-1071 
Sept. 1989-June 1990 
Pharmaceutical Manufacturer's Association Foundation 
Postdoctoral Fellow in clinical Pharmacology 
university of Georgia 
Athens, GA 30602 
1986-1989 
Ophthalmology Resident 
College of veterinary Medicine 
university of Georgia 
Athens, GA 30602 
1985-1986 
Small Animal Clinician 
East North veterinary Clinic 
Greenville, SC 
BOARD CERTIFICATION 
Board certified by the American College of Veterinary 
Ophthalmologists 1991. 
PROFESSIONAL ORGANIZATIONS 
American College of Veterinary Ophthalmologists 
American Society of Veterinary Ophthalmology 
Association for Research in Vision and Ophthalmology 
American veterinary Medical Association 
Phi Zeta Society 
HONORS 
Pharmaceutical Manufacturer's Association Foundation Postdoctoral 
Fellowship in Clinical Pharmacology, 1988 
American Academy of Veterinary Pharmacology and Therapeutics 
Travel Award, 1988 
Phi Zeta - University of Tennessee, 1985 
American Society of Animal Science Scholarship Award - Middle 
Tennessee State University, 1982 
Alpha Chi (Theta Chapter) - Christian Brothers College, 1981 
PUBLICATIONS 
Articles 
Burgess H, Ward DA. The effects of topical 1% aproclonidine 
hydrochloride on the intraocular pressure of normal canine 
subjects, in preparation 2/94. 
Ward DA. Blood-aqueous barrier stabilizing effect of 
flurbiprofen, diclofenac, tolmetin, and suprofen. Arch 
ophthalmol, submitted 2/94. 
Ward DA. Oculomycoses. In Kirk RW (ed): Current veterinary 
Therapy X. Philadelphia: WB Sanders Co., in press. 
Ward DA, Lakritz J, Bauer RW. Scleral mastocytosis in a horse. 
Eq vet J 25: 79-80, 1993. 
Ward DA, Ferguson DC, Ward SL, Green K, Kaswan RL. Comparison of 
the blood-aqueous barrier stabilizing effects of steroidal and 
nonsteroidal antiinflammatory agents in the dog. Prog vet Compar 
ophthalmol 2: 117-124, 1992. 
Ward DA, Ferguson DC, Kaswan RL, Green K. Leukotrienes and 

sensory innervation in blood-aqueous barrier disruption in the 

dog. JOcular Pharm 8: 69-76, 1992. 
Ward OA, Latimer KS, Askren RM. Squamous cell carcinoma of the 
corneoscleral limbus in a dog. J Am Vet Med Assoc 200: 1503­
1506, 1992. 
sims MH, Ward OA. Response of transient pattern­
electroretinograms (PERG) in dogs to alterations in the spatial 
frequency of the stimulus. Prog Vet Comp Ophthalmol, 2: 106-112, 
1992. 
Martin CL, Kaswan R, Gratzek A, Champagne E, Salisbury MA, Ward 
OA. Ocular use of tissue plasminogen activator in companion 
animals. Prog Vet Compar ophthalmol 3: 29-36, 1992. 
Ward OA, Clark ES. Ocular Pharmacology. Veterinary Clinics of 
North America: Food Animal Practice 7: 779-791, 1991. 
Ward OA, Ferguson DC, Kaswan RL, Green K, Bellhorn RW. 
Fluorophotometric evaluation of experimental blood-aqueous 
barrier breakdown in dogs. Am J Vet Res 52: 1433-1437, 1991. 
Salisbury MA, Kaswan RL, Ward OA, Martin CL, Ramsey JM, Fischer 
CA. Topical application of cyclosporine in the management of 
keratoconjunctivitis sicca in dogs. J Am Anim Hosp Assoc 26: 
269-274, 1990. 
Ward OA, Martin CL, Weiser I. Band keratopathy associated with 
hyperadrenocorticism in the dog. J Am Anim Hosp Assoc 25:583­
586, 1989. 
Ward OA. New trends in veterinary ocular pharmacology. Georgia 
veterinarian 41:8-9, 1989. 
Martin, CL, Ward OA. Medical therapy of glaucoma. In Kirk RW 
(ed): Current Veterinary Therapy X. Philadelphia: WB Sanders 
Co., 1989, pp. 647-651. 
Kaswan RL, Salisbury MA, Ward OA. Spontaneous canine 
keratoconjunctivitis sicca. A useful model for human 
keratoconjunctivitis sicca: Treatment with cyclosporin eyedrops. 
Arch ophthalmol 1989; 107:1210-1216. 
Abstracts 
Ward OA, Ferguson 0, Ward S, Green K, Kaswan R. Comparison of 
the blood-aqueous barrier stabilizing effects of steroidal and 
nonsteroidal antiinflammatory agents in the dog. Vet Pathol 
1992; 29:480. 
Ward OA, Kaswan RL, Green K, Bellhorn RW. Fluorophotometric 
evaluation of experimental acute anterior uveitis in the dog. 
Trans Am Col Vet ophthalmol 1988; 19:113. 
Ward OA, Kaswan RL, Martin CL. Ocular granulomatous 
meningoencephalitis in a dog. Tran Am Col vet ophthalmol 1987; 
18:307. 
sims MH, Ward OA. Response of transient pattern­
electroretinograms (PERG) in dogs to alterations in the spatial 
frequency of the stimulus. Proe Am Coll vet Internal Med, May 
1993. 
Martin CL, Kaswan R, Gratzek A, Champagne E, Salisbury MA, ~ 
OA. Ocular use of tissue plasminogen activator. Vet Pathol 
1992; 29:472. 
Kaswan RL, Salisbury MA, Ward OA, Martin CL, Fischer CA, Ramsey 
JM, Kemp OT. Topical application of cyclosporine: A new method 
to increase tear production for keratoconjunctivitis sicca. 
Trans Am Col Vet Ophthalmol 1987; 18:296. 
Kaswan RL, Fischer CA, Ward OA, Martin CL, Ramsey JM. Clinical 
trials of ophthalmic cyclosporine in chronic keratitis. Trans Am 
Col Vet Ophthalmol 1987; 18:276-295. 
PRESENTATIONS 
National and Reqional Heetinqs 
American College of Veterinary Ophthalmologists, Fort Worth TX. 
"Ocular granulomatous meningoencephalitis in a dog," November 
1987. 
American College of Veterinary Ophthalmologists, Las Vegas NV. 
"Fluorophotometric evaluation of experimental acute anterior 
uveitis in the dog," October 1988. 
American College of Veterinary Ophthalmologists, San Diego CA. 
"Comparison of the blood-aqueous barrier stabilizing effects of 
steroidal and nonsteroidal antiinflammatory agents in the dog," 
November 21, 1992. 
Johns Hopkins Center for Alternatives to Animal Testing, 
Baltimore MD. "In vitro model of the blood-ocular barriers as an 
aid in oculotoxicity testing," February 23, 1994. 
continuinq Education seminars 
Greenville Veterinary Medical Association, Greenville, SC. 
"Canine glaucoma," 2 hours, January 1988. 
East Tennessee Veterinary Medical Association, Gatlinburg, TN. 
"Equine keratitis," 3 hours, October 3, 1992. 
University of Tennessee College of Veterinary Medicine continuing 
Education Conference, Knoxville TN. "Update on ophthalmic 
drugs," 1 hour, December 7, 1992. 
University of Tennessee College of Veterinary Medicine Feline 
Club, Knoxville TN. "Case presentations in feline 
ophthalmology," 1 hour, September 15, 1993. 
University of Georgia college of veterinary Medicine: 
Physiology/Pharmacology Seminar 
"Anterior segment slit-lamp fluorophotometry in the dog" ­
February 1988. 
"Experimental blood-aqueous barrier breakdown in the dog" ­
November 1988. 
university of Georgia college of veterinary Medicine: continuing 
Education Program. 
"Inherited and Congenital diseases of the ocular fundus" ­
February 1987. 
university of Tennessee Intern/Resident seminar series 
8 lectures, various ophthalmological topics, Spring 1991 . 
.. 
"Ocular Emergencies" - July 1992. 
"Keratitis" and "Anterior Uveitis" - February 1993. 
"Ocular Emergencies" - July 1993. 
"Corneal Opacification" and "Case Discussions" - February 1994 
"Biostatistics" - 5 hour series 2/94 - 6/94 
university of Tennessee Grand Rounds Series 
"Odontogenic Keratocyst in a Dog" - AprilS, 1992. 
"Ocular Blastomycosis in a Dog" - 1992. 
"Myasthenia Gravis Presenting as Blepharoptosis in a Dog" ­
Sept.10, 1993 
Lay Audience Presentations 
"Ocular emergencies" - Greater Atlanta Boxer Association, 
February 1988. 
"Ocular diseases affecting the Bulldog" - Atlanta Bulldog 
Association, September 1989. 
"Feline ophthalmology" - Knoxville Feline Club, February 20, 
1992. 
RESEARCH EXPERIENCE 
Grants 
"Chemomodulation of the canine blood-aqueous barrier: 
Evaluation by fluorophotometry" 
Principle author: Ward DA 
Principle investigator: Kaswan RL 
Co-investigators: Ward DA, Kaswan RL, Martin CL, Ferguson DC 
Funding: Funded by the University of Georgia Veterinary 
Medical Exp station, $5,100, June 1987 
a. Grant renewal 
VMES, $2,000, 
funded by the University of Georgia 
June 1988. 
b. Grant renewal 
VMES, $4,600, 
funded by the University of Georgia 
June 1989. 
"A quantitative model of uveitis in the dog" 
AVMA Foundation Research Grant Program 
Principle author: Ward DA 
Principle investigator: Kaswan RL 
Co-investigators: Ward DA 
Funding: Ranked in top 25% of 214 proposals submitted and 
approved funding, but not funded due to limitation 
of available funds. 
"Comparison of ocular anti-inflammatory drugs in the dog: 
Evaluation by fluorophotometry." 
Solvay Resident Grant Competition, 1989 
Principle author: Ward DA 
Principle investigator: Ward DA 
Funding: Selected as finalist in competition but not 
selected as an awardee. 
"Pharmacologic management of bood-aqueous barrier disruption 
in dogs." 
Principle investigator: Ward DA 
Funding: UT Centers of Excellence, $5,000; Small Animal 
Research, $3,000. 
"Characterization of PGE2 receptors in canine iris-ciliary body 
membrane preparations." 
Principle investigator: Ward DA 
Co-investigator: Frazier DA 
Funding: UTCVM Venture Grant, $2,900; UTCVM Department of 
Urban Practice, $1,000. 
"Evaluation and comparison of two surgical techniques for 
the treatment of canine glaucoma." 
Principle investigator: Ward DA 
Co-investigator: Morgan RV 
Funding: Companion Animal Fund, $3,560. 
"In vitro model of the porcine blood-aqueous barrier." 

Principle investigator: Ward DA 

Co-investigators: Rowles T, Frazier 0, Schultz T 

Funding: UTCVM Venture Grant, $3,400. 

"In vitro model of the blood-ocular barriers as an aid in 

oculotoxicity testing." 
Principle investigator: Ward DA 
Co-investigaotrs: Rowles T, Frazier 0, Schultz T 
Funding: Johns Hopkings Center for Alternatives to Animal 
Testing, $30,000, 2/1/94. 
"Isolation of and indirect immunofluorescent testing for 
Chlamydia psittaci in cats with conjunctivitis." 
principle investigator: Ward DA 
Co-investigators: Kennedy M, Legendre A, Potgeiter L, Morgan R, 
Grove C 
Funding: Intervet, Inc., $5,000. 
"Effect of topical demecarium bromide on systemic 
acetylcholinesterase levels in dogs." 
Principle Investigator: Ward DA 
Co-investigators: Abney K, Israel J 
Funding: UTCVM Companion Animal Fund, $382.10. 
"The effects of topical 1% aproclonidine hydrochloride on the 
intraocular pressure of normal canine subjects." 
Principle Investigator: Ward DA 
Co-investigator: Burgess H 
Funding: UTCVM Small Animal Research, $1,760. 
"In vitro model of the blood-ocular barriers as an aid in 
oculotoxicity testing." 
Principle Investigator: Ward DA 
Funding: pendinq -- UTCVM Centers of Excellence, $15,681 
requested 3/94. 
"In vitro model of the blood-aqueous barrier as an aid in 
oculotoxicity testing." 
Principle Investigator: Ward DA 
Co-investigator: Rowles TA, Frazier 0, Schultz TW 
Funding: pendinq -- Fight for Sight, the Research Division of 
the National Society to Prevent Blindness, $12,000 requested 
3/94. 
Current Investiqations 
Evaluation and comparison of two surgical techniques for the 

treatment of canine glaucoma. 

Comparison of 3 surgical techniques for the treatment of canine 

distichiasis. 

Isolation of and indirect immunofluorescent testing for Chlamydia 
psittaci in cats with conjunctivitis. 
CONTINUING EDOCATION COURSES ATTENDED 
American Society of Veterinary Ophthalmology, Atlanta, GA, June 
1986. 
American College of Veterinary ophthalmologists Annual Meeting, 
Fort Worth, Texas, November 1987. 
Basic Sciences Course in Ophthalmology, Stanford University 
School of Medicine, Palo Alto, CA, July 1988-September 1988. 
Phacoemulsification/Intraocular Lens Implantation Short Course, 
University of California School of Veterinary Medicine, Davis, 
California, June 1989. 
American College of Veterinary Ophthalmologists Annual Meeting, 
New Orleans, Louisiana, October 1989. 
American College of Veterinary Ophthalmologists Annual Meeting, 
San Diego CA, November 1992. 
TEACHING EXPERIENCE 
Small Animal General Surgery - SMS 540 (University of Georgia) 
Assistance in ophthalmology portion of student surgery 
laboratory, spring Quarter 1987 & 1988 
Studies in Small Animal Clinical Medicine - SM 590 (University of 
Georgia) 
Clinical rotation in ophthalmology - Participation totaling 
60 weeks during the period September 1986-September 1989 
Small Animal Medicine - SMS 520 (University of Georgia) 
Limited participation in didactic ophthalmology lectures, 
1988 & 1989 
Small Animal Medicine - SMS 521 (University of Georgia) 

Limited participation in didactic pharmacology lectures, 

1989 

Special Senses - VM856 (University of Tennessee) 

Didactic ophthalmology lectures (11) and laboratories (5), 

Fall 1990, Winter 1992, Winter 1993, Winter 1994. 

Veterinary Medical Technology - AS496 (University of Tennessee) 
Technology used in the practice of veterinary ophthalmology 
(1 hr), 4/15/93, 3/31/94. 
COMMITTEE ASSIGNMENTS 
College of Agriculture Advisory Council, student Development 

Subcommittee, member, 1991 - present. 

Postdoctoral/Resident Committee, member, 1992-present. 

Educational computing Committee, member, 1993-present. 

Committee to Formulate Guidelines for Visiting Foreign 

Veterinarians, chairman, 1993. 

MISCELLANEOUS 
Mentor for ophthalmology section of UTCVM Open House, 1991, 1992, 

1993. 

Presentation on careers in veterinary medicine, Farragut High 

School Career Day, Spring 1991. 

Participant in UT Academy for Teachers of Science and Mathematics 
program at UTCVM, July 8, 1992. 
Arranged Departmental Christmas party, December 1992. 

participant in UTCVM/Knoxville Zoo "Teddy Bear Picnic," July 

1993. 

Participant in UTCVM Field Day for West High School Physiology 

Class, 3/3/93. 

Tour of UTCVM for Blount County elementary school students, 

1/28/94. 

Active involvement in use of computer generated teaching methods: 
Gave continuing education course using this format December 1992, 
presented one lecture for VM856 using this format March 1994. 
Presenter, 1993 Last Lecture Series on behalf of the Class of 

1994. 

Advisor, Student Chapter of the AVMA, 1993-present. 

Tour of UTCVM for Leadership Education conference, 3/18/94. 
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